Video Experimental Relacionado
Updated: Aug 6, 2026
11:12
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
Published on: August 1, 2018
Caracterización molecular de tumores de tejidos blandos: un estudio de expresión génica
Torsten O Nielsen1, Rob B West, Sabine C Linn
1Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
Lancet (London, England)
|April 20, 2002
Resumen
Este estudio revela distintos patrones de expresión génica en tumores de tejidos blandos, lo que sugiere un nuevo método de clasificación molecular. Los genes no caracterizados pueden servir como nuevos marcadores de diagnóstico y dianas terapéuticas para estas neoplasias raras.
Área de la Ciencia:
- Oncología Oncología.
- La genómica es la genómica.
- Biología Molecular Biología Molecular
Sus antecedentes:
- Los tumores de tejidos blandos se originan en células mesenquimales, pero su histogénesis a menudo no está clara.
- La caracterización molecular de las neoplasias raras es crucial para comprender sus orígenes.
- Se necesita una búsqueda en todo el genoma de nuevos marcadores de diagnóstico.
Objetivo del estudio:
- Para iniciar la caracterización molecular de tumores raros de tejidos blandos.
- Identificar nuevos marcadores de diagnóstico a través del análisis de todo el genoma.
Principales métodos:
- Los patrones de expresión génica de 41 tumores de tejidos blandos se analizaron utilizando microarrays de ADNc manchado.
- Se empleó agrupación jerárquica y descomposición de valor singular para agrupar tumores basados en la expresión génica.
- El preprocesamiento de datos implicó la eliminación de errores de diferentes lotes de microarrays.
Principales resultados:
- Se observaron patrones de expresión génica distintos en los sarcomas sinoviales, los tumores del estroma gastrointestinal, los tumores neurales y un subconjunto de los leiomiosarcomas.
- El histiocitoma fibroso maligno, el liposarcoma y otros leiomiosarcomas mostraron perfiles moleculares compartidos no predichos por la histología o la inmunohistoquímica.
- Ambos genes conocidos (por ejemplo, KIT) y numerosos genes no caracterizados contribuyeron a distinguir los tipos de tumores.
Conclusiones:
- El perfil de expresión génica ofrece un enfoque novedoso para la clasificación de tumores de tejidos blandos, superando potencialmente los métodos histológicos tradicionales.
- Los genes no caracterizados identificados en este estudio pueden tener potencial como marcadores de diagnóstico, indicadores de pronóstico o objetivos terapéuticos.
- Este enfoque molecular proporciona nuevos conocimientos sobre la heterogeneidad de los tumores de tejidos blandos.
Videos de Conceptos Relacionados
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...